Figure 1.
Silencing DANCR inhibits colon cancer cell growth in vitro. (A) Fold change of DANCR in human colon cancer cell lines and normal human epithelial cells (HCoEpiC). DANCR was examined by RT-qPCR and normalized to GAPDH expression (P<0.01). (B) SW480 and (C) HCT15 cell lines were infected with lentivirus-based shRNA targeting DANCR and NC. The fold change of DANCR were examined by RT-qPCR and normalized to GAPDH expression (P<0.01). (D) Cell Counting kit-8 assay was performed to detect the cell viability of SW480-shNC and SW480-shDANCR cells at 0, 24, 48 and 72 h post cell plating (P<0.05, P<0.01). (E) Cell Counting kit-8 assay was performed to detect the cell viability of HCT15-shNC and HCT15-shDANCR cells at 0, 24, 48 and 72 h post cell plating (P<0.05, P<0.01). (F) Colony formation assay was performed in SW480-shNC and SW480-shDANCR cells. The number of colonies was analyzed (P<0.01). (G) Colony formation assay was performed in HCT15-shNC and HCT15-shDANCR cells. The number of colonies was analyzed (P<0.01). *P<0.05 and **P<0.01 vs. shNC. shDANCR, short hairpin differentiation antagonizing non-protein coding RNA; shRNA, short hairpin ribonucleic acid; NC, negative control; RT-qPCR, reverse transcription-quantitative polymerase chain reaction.
